Ovid Therapeutics (OVID) Q1 2026 Earnings

16MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.17
-0.13
-0.1
-0.06

Details

Expected EPS
-0.11708
Actual EPS
N/A
Surprise EPS
0.12
Surprise Percent
+100%

Description

Ovid Therapeutics (OVID) will report earnings of for Q1 2026 on March 16, 2026.

0 Comments

Share your thoughts